Efficacy of Combination of Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ: IgG Fc Fusion Protein for Injection and Methotrexate in the Treatment of Moderate and Severe Plaque Psoriasis

CHEN Yansong

doi:10.14033/j.cnki.cfmr.2022.17.009

Home>Articles>Efficacy of Combination of Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ: IgG Fc Fusion Protein for Injection and Methotrexate in the Treatment of Moderate and Severe Plaque Psoriasis

DOI: 10.14033/j.cnki.cfmr.2022.17.009

Efficacy of Combination of Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ: IgG Fc Fusion Protein for Injection and Methotrexate in the Treatment of Moderate and Severe Plaque Psoriasis

CHEN Yansong

Machine-generated Keywords：

Publication Date：2022-06-15

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 33-37 )

Chinese and Foreign Medical Research

ISSN：1674-6805

Year, Vol.(Issue)：2022,20(17)